[go: up one dir, main page]

TR201818886T4 - Bir ilave antidiyabetik ajanla kombine edilmiş dpp-ıv inhibitörü, bu formülasyonları içeren tabletler, bunların kullanımları ve bunları hazırlama prosesi. - Google Patents

Bir ilave antidiyabetik ajanla kombine edilmiş dpp-ıv inhibitörü, bu formülasyonları içeren tabletler, bunların kullanımları ve bunları hazırlama prosesi. Download PDF

Info

Publication number
TR201818886T4
TR201818886T4 TR2018/18886T TR201818886T TR201818886T4 TR 201818886 T4 TR201818886 T4 TR 201818886T4 TR 2018/18886 T TR2018/18886 T TR 2018/18886T TR 201818886 T TR201818886 T TR 201818886T TR 201818886 T4 TR201818886 T4 TR 201818886T4
Authority
TR
Turkey
Prior art keywords
dpp
preparation
formulations
tablets containing
antidiabetic agent
Prior art date
Application number
TR2018/18886T
Other languages
English (en)
Inventor
Friedl Thomas
Braun Michael
Egusa Kenji
Fujita Hikaru
Maruyama Megumi
Nishioka Takaaki
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66630027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201818886(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TR201818886T4 publication Critical patent/TR201818886T4/tr

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş, bir DPP-4 inhibitörü ilacı ile bir partner ilacın sabit doz kombinasyonlarını içeren farmasötik bileşimlerle, bunları hazırlama amacına yönelik proseslerle ve bunların belirli hastalıkların tedavisinde kullanılmalarıyla ilgilidir.
TR2018/18886T 2008-04-03 2009-04-02 Bir ilave antidiyabetik ajanla kombine edilmiş dpp-ıv inhibitörü, bu formülasyonları içeren tabletler, bunların kullanımları ve bunları hazırlama prosesi. TR201818886T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08154039 2008-04-03
US8734308P 2008-08-08 2008-08-08

Publications (1)

Publication Number Publication Date
TR201818886T4 true TR201818886T4 (tr) 2019-01-21

Family

ID=66630027

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/18886T TR201818886T4 (tr) 2008-04-03 2009-04-02 Bir ilave antidiyabetik ajanla kombine edilmiş dpp-ıv inhibitörü, bu formülasyonları içeren tabletler, bunların kullanımları ve bunları hazırlama prosesi.

Country Status (3)

Country Link
CL (1) CL2009000809A1 (tr)
HU (1) HUE041649T2 (tr)
TR (1) TR201818886T4 (tr)

Also Published As

Publication number Publication date
CL2009000809A1 (es) 2010-04-09
HUE041649T2 (hu) 2019-05-28

Similar Documents

Publication Publication Date Title
MX351232B (es) Inhibidor de dpp-iv combinado con otro agente antidiabetico, tabletas que comprenden tales formulaciones, su uso y procedimiento para su preparacion.
CY1118661T1 (el) Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων
ECSP088974A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
MX2012012438A (es) Formulaciones farmaceuticas que comprenden pioglitazona y linagliptina.
MX384206B (es) Formulaciones de inhibidores de dpp iv
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
BRPI0916668A2 (pt) composições e métodos para anticorpos direcionados à proteína do complemento c5
BRPI0915084B8 (pt) composto, e, composição farmacêutica
SV2010003451A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
MX374797B (es) Formulaciones farmaceuticas que contienen hidrato de propilenglicol de dapagliflozina.
EA200901138A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
CR11455A (es) Compuestos nuevos de hidrocarbono ciclico para el tratamiento de enfermedades
ECSP088904A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
UY30759A1 (es) Compuestos quimicos
CL2007001166A1 (es) Compuestos derivados de pirimidina condensada, inhibidores de pi3-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicion farmaceutica
EA201070421A1 (ru) Микрорибонуклеиновые кислоты
MX347525B (es) Inhibidores de tirosina cinasa de bruton.
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
EA201171497A1 (ru) Снижение флуктуаций опиоидов в крови
MX2012005689A (es) Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos.
WO2009099553A3 (en) Use of kinase inhibitor in treatment of atherosclerosis
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
CL2007003251A1 (es) Compuestos derivados de 1h-pirazoles sustituidos, inhibidores de reacciones catalizadas por una quinasa; su procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; uso de los compuestos principales, utiles en el tratamiento del cancer.
GB201014391D0 (en) Drug composition and its use in therapy
EA201171414A1 (ru) Ингибиторы белков семейства iap